Compare RCUS & ACMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCUS | ACMR |
|---|---|---|
| Founded | 2015 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.5B |
| IPO Year | 2018 | 2017 |
| Metric | RCUS | ACMR |
|---|---|---|
| Price | $22.00 | $52.71 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | $28.89 | ★ $43.00 |
| AVG Volume (30 Days) | ★ 1.6M | 1.4M |
| Earning Date | 02-24-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.16 |
| EPS | N/A | ★ 1.72 |
| Revenue | $240,000,000.00 | ★ $880,350,000.00 |
| Revenue This Year | N/A | $18.22 |
| Revenue Next Year | N/A | $16.80 |
| P/E Ratio | ★ N/A | $31.11 |
| Revenue Growth | N/A | ★ 20.77 |
| 52 Week Low | $6.50 | $16.81 |
| 52 Week High | $26.40 | $54.83 |
| Indicator | RCUS | ACMR |
|---|---|---|
| Relative Strength Index (RSI) | 47.16 | 75.51 |
| Support Level | $20.59 | $49.50 |
| Resistance Level | $23.40 | $54.36 |
| Average True Range (ATR) | 1.39 | 2.48 |
| MACD | -0.07 | 0.66 |
| Stochastic Oscillator | 32.38 | 91.02 |
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
ACM Research Inc supplies advanced, innovative capital equipment developed for the world-wide semiconductor industry. Fabricators of advanced integrated circuits, or chips, can use its wet-cleaning and other front-end processing tools in numerous steps to improve product yield, even at increasingly advanced process nodes. It has designed these tools for use in fabricating foundry, logic and memory chips, including dynamic random-access memory, or DRAM, and 3D NAND-flash memory chips. The company also develops, manufactures and sells advanced packaging tools to wafer assembly and packaging customers.